Results 241 to 250 of about 26,165 (305)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 6, Page 1376-1385, June 2026.
Abstract Objective This study was conducted to characterize the prevalence, temporal patterns, and the degree of vomiting‐induced migraine pain relief (VIMPR). Background Although data in the literature and anecdotal patient reports indicate the occurrence of VIMPR, its detailed characterization remains unstudied.
Antonio Munafò   +5 more
wiley   +1 more source

Diabetes and Delayed Wound Healing: Molecular Mechanisms and Dermatological Interventions

open access: yesInternational Wound Journal, Volume 23, Issue 6, June 2026.
ABSTRACT Diabetes mellitus is a global burden that affects wound healing at nearly every stage, transforming what should be a coordinated and self‐limited repair process into a chronic, non‐healing state. In diabetic patients, sustained hyperglycemia drives persistent inflammation, impaired angiogenesis, fibroblast dysfunction and extracellular matrix ...
Sasha Jreije   +4 more
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Clinical Study of Narrow‐Band Intense Pulsed Light with Different Parameters in the Treatment of Erythematotelangiectatic rosacea: A Retrospective Study

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Object To explore the clinical efficacy of a narrow‐band intense pulsed light (DPL) with different energy density in the treatment of erythematotelangiectatic rosacea (ETR). Methods A retrospective study was conducted on patients diagnosed with erythema telangiectatic rosacea who received 5 DPL treatment sessions in the laser cosmetology ...
Lingling Yang   +2 more
wiley   +1 more source

Neuroimmune Crosstalk in Psoriasis: Mechanisms and Therapeutic Implications. [PDF]

open access: yesInflammation
Gao H   +5 more
europepmc   +1 more source

Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis

open access: yesThe FASEB Journal, Volume 40, Issue 10, 31 May 2026.
Osteoblast‐derived matricellular protein osteomodulin (OMD) critically regulates bone remodeling homeostasis via directly and competitively binding to RANKL, the master cytokine driving osteoclast formation. OMD shares overlapping binding sites on RANKL with osteoprotegerin and functional receptor RANK.
Meiling Jing   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy